Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Researchers search for a link between heart disease, psoriasis

Psoriasis elevates the number of skin cells on the elbows, knees and across the body. And according to a new study, it can also elevates the risk of heart disease.

Thumbnail

Pacemaker implantations following TAVR may be more common than previously thought

Studies have shown that permanent pacemaker implantation is among the most common complications for patients undergoing transcatheter aortic valve replacement (TAVR). Still, the risk may be underestimated, according to a recent analysis.

New FDA-approved drug treats cardiovascular disease, type 2 diabetes

Jardiance, a medication designed to reduce the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular disease, was approved by the U.S. Food and Drug Administration (FDA) this week, making it the first type 2 diabetes treatment of its kind.

FDA expands approval of Impella heart pumps for use in high-risk PCIs

The FDA expanded the approval of Abiomed’s premarket approval for the company’s Impella CP heart pump for use in high risk PCIs.

College football linemen at increased risk of hypertension

Changes in blood pressure and thickening of the heart walls are seen more often in this specific position. 

Breakfast cereal does the heart good

New research reveals the mechanism by which healthy cereals reduce the amount of cholesterol in the blood stream. 

Thumbnail

Alcohol remains major risk factor for atrial fibrillation

Studies have shown that small amounts of alcohol could reduce the incidence of coronary disease. However, a recent review found that the benefits of alcohol do not apply to atrial fibrillation. In fact, the researchers noted that alcohol was a risk factor for atrial fibrillation, also known as an irregular heartbeat.

Biotronik enrolls first patients in study evaluating BioMonitor 2 in office setting

Biotronik announced Dec. 5 that the first patients had enrolled in the BioInsight trial, which is evaluating the use of the BioMonitor 2 in an office setting.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.